Limits...
Development and validation of a severity scale for leprosy type 1 reactions.

Walker SL, Nicholls PG, Butlin CR, Nery JA, Roy HK, Rangel E, Sales AM, Lockwood DN - PLoS Negl Trop Dis (2008)

Bottom Line: Removal of three items from the original scale resulted in better discrimination between disease severity categories.A moderate reaction is a score of between 4.5 and 8.5.A severe reaction is a score of 9 or more.

View Article: PubMed Central - PubMed

Affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Steve.Walker@lshtm.ac.uk

ABSTRACT

Objectives: To develop a valid and reliable quantitative measure of leprosy Type 1 reactions.

Methods: A scale was developed from previous scales which had not been validated. The face and content validity were assessed following consultation with recognised experts in the field. The construct validity was determined by applying the scale to patients in Bangladesh and Brazil who had been diagnosed with leprosy Type 1 reaction. An expert categorized each patient's reaction as mild or moderate or severe. Another worker applied the scale. This was done independently. In a subsequent stage of the study the agreement between two observers was assessed.

Results: The scale had good internal consistency demonstrated by a Cronbach's alpha >0.8. Removal of three items from the original scale resulted in better discrimination between disease severity categories. Cut off points for Type 1 reaction severities were determined using Receiver Operating Characteristic curves. A mild Type 1 reaction is characterized using the final scale by a score of 4 or less. A moderate reaction is a score of between 4.5 and 8.5. A severe reaction is a score of 9 or more.

Conclusions: We have developed a valid and reliable tool for quantifying leprosy Type 1 reaction severity and believe this will be a useful tool in research of this condition, in observational and intervention studies, and in the comparison of clinical and laboratory parameters.

Show MeSH

Related in: MedlinePlus

ROC curve for mild and moderate cases and moderate and severe cases.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2596969&req=5

pntd-0000351-g004: ROC curve for mild and moderate cases and moderate and severe cases.

Mentions: The ROC curve for the final scale scores was plotted for individuals identified as mild or moderate by the expert raters and for those categorized as moderate or severe (Fig. 4). This facilitates the determination of cut off scores for each category [13].


Development and validation of a severity scale for leprosy type 1 reactions.

Walker SL, Nicholls PG, Butlin CR, Nery JA, Roy HK, Rangel E, Sales AM, Lockwood DN - PLoS Negl Trop Dis (2008)

ROC curve for mild and moderate cases and moderate and severe cases.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2596969&req=5

pntd-0000351-g004: ROC curve for mild and moderate cases and moderate and severe cases.
Mentions: The ROC curve for the final scale scores was plotted for individuals identified as mild or moderate by the expert raters and for those categorized as moderate or severe (Fig. 4). This facilitates the determination of cut off scores for each category [13].

Bottom Line: Removal of three items from the original scale resulted in better discrimination between disease severity categories.A moderate reaction is a score of between 4.5 and 8.5.A severe reaction is a score of 9 or more.

View Article: PubMed Central - PubMed

Affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Steve.Walker@lshtm.ac.uk

ABSTRACT

Objectives: To develop a valid and reliable quantitative measure of leprosy Type 1 reactions.

Methods: A scale was developed from previous scales which had not been validated. The face and content validity were assessed following consultation with recognised experts in the field. The construct validity was determined by applying the scale to patients in Bangladesh and Brazil who had been diagnosed with leprosy Type 1 reaction. An expert categorized each patient's reaction as mild or moderate or severe. Another worker applied the scale. This was done independently. In a subsequent stage of the study the agreement between two observers was assessed.

Results: The scale had good internal consistency demonstrated by a Cronbach's alpha >0.8. Removal of three items from the original scale resulted in better discrimination between disease severity categories. Cut off points for Type 1 reaction severities were determined using Receiver Operating Characteristic curves. A mild Type 1 reaction is characterized using the final scale by a score of 4 or less. A moderate reaction is a score of between 4.5 and 8.5. A severe reaction is a score of 9 or more.

Conclusions: We have developed a valid and reliable tool for quantifying leprosy Type 1 reaction severity and believe this will be a useful tool in research of this condition, in observational and intervention studies, and in the comparison of clinical and laboratory parameters.

Show MeSH
Related in: MedlinePlus